Differential glucose tolerance in dipper and nondipper essential hypertension: The implications of circadian blood pressure regulation on glucose tolerance in hypertension

Diabetes Care

Volumn 21, Issue 10, 1998, Pages 1743-1748

  Chen, Jaw Wen ^a   Jen, Shu Long ^a   Lee, Wen Lieng ^b   Hsu, Nai Wei ^a   Lin, Shing Jong ^a   Ting, Chih Tai ^b   Chang, Mau Song ^a   Wang, Ping H ^c  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ADULT; ARTICLE; AUTONOMIC NERVOUS SYSTEM FUNCTION; BLOOD PRESSURE MONITORING; CIRCADIAN RHYTHM; CLINICAL ARTICLE; ESSENTIAL HYPERTENSION; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; HUMAN; HYPERTENSION; MALE; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET CELL FUNCTION;

ADULT; ALDOSTERONE; AUTONOMIC NERVOUS SYSTEM; BLOOD GLUCOSE; BLOOD PRESSURE; CATECHOLAMINES; CHOLESTEROL; CIRCADIAN RHYTHM; DIASTOLE; EPINEPHRINE; FEMALE; GLUCOSE TOLERANCE TEST; HEART RATE; HUMANS; HYPERTENSION; MALE; NOREPINEPHRINE; POSTPRANDIAL PERIOD; SYSTOLE; TRIGLYCERIDES;

EID: 0031689055     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.21.10.1743     Document Type: Article

References (25)

1. Shen D, Shieh S, Fuh D, Wu D, Chen Y, Reaven GM: Resistance to insulin-stimulated glucose uptake in patients with hypertension, J Clin Endocrinol Metdb 66:580-583, 1988
2. Reaven GM, Lilhell H, Landsberg L: Hyper-tension and associated metabolic abnormalities: the role of insulin resistance and the sympathoadrenal system. N Engl J Med 334:374-381, 1996
3. Lapinski M, Lewandowski J, Januszewicz A, Kuch-Wocial A, Symonides B, Wocial B: Hormonal profile of dipper and non-dipper patients with essential hypertension. J Hypertens 11 (Suppl. 5):S294-S295, 1993
4. Kohara K, Nishida W, Maguchi M, Hiwada K: Autonomic nervous function in non-dipper essential hypertensive subjects: evaluation by power spectral analysis of heart rate variability Hypertension 26:808-814, 1995
5. Lembo G, Capaldo B, Rendina V, laccarino G, Napoli R, Guida R, Trimarco B, Sacca L: Acute noradrenergic activation induces insulin resistance in human skeletal muscle. Am J Physiol 266:E242-E247, 1994
6. Akiba M, Kodama T, Ito Y, Obara T, Fujimoto Y: Hypoglycemia induced by excessive rebound secretion of insulin after removal of pheochromocytoma. World J Surg 14:317-324, 1990
7. Desbuquois B, Aurbach AD: Use of polyethylene glycol to separate free and anti-body-bound peptide hormones in radioimmunoassay. J Clin Endocrinol Metab 33:732-738, 1971
8. O'Brien E, Mee F, Atkins N, Halligan A, O'Mallcy K: Accuracy of the SpaceLabs 90207 ambulatory blood pressure measuring system in normotensive pregnant women determined by the British Hypertension Society protocol. J Hypertens 11 (Suppl. 5):S282-S283, 1993
9. Chen CH, Ting CT, Lin SJ, Hsu TL, Chou PS, Kuo H, Wang SU Yin FC, Chang MS: Relation between diurnal variation of blood pressure and left ventricular mass in a Chinese population. Am J Cardiol 75:1239-1243, 1995
10. Lee WL,Chen JW, Kong CH, Wang JJ, Ting CT, Chan WL, Wang SP, Chang MS: Changes in cardiac autonomic activities in patients with syndrome X: a study of spectral analysis of heart rate variability. Angiology 47:929-939, 1996
11. Bouloux PM, Perrett D: Interference of labetalol metabolites in the determination of plasma catecholamines by HPLC with electrochemical detection. Clin Chim Acta 150:111-117, 1985
12. Schleicher ED, Kees FK, Wieland OH: Analysis of total urinary catecholamines by liquid chromatography: methodology, routine experience and clinical interpretations of results. Gin Chim Acta 129:295-302, 1983
13. Tillil H, Shapiro ET, Miller MA, Karrison T, Frank BH, Galloway JA, Rubenstein AH, Polonsky KS: Dose-dependent effects of oral and intravenous glucose on insulin secretion and clearance in normal humans. Am J Physiol 254:E349-E357, 1988
14. Zavaroni I, Coruzzi P, Bonini L, Mossini GL, Musiari L, Gasparini P, Fantuzzi M, Reaven GM: Association between salt sensitivity and insulin concentrations in patients with hypertension. Am J Hypertens 8:855-858, 1995
15. Facchini F, Chen YD, Clinkingbeard C, Jeppesen J, Reaven GM: Insulin resistance, hyperinsulinemia, and dyslipidemia in nonobese individuals with a family history of hypertension. Am J Hypertens 5:694-699, 1992
16. Mitrakou A, Kelley D, Mokan M, Veneman T, Pangbum T, Reilly J, Gerich J: Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance. N Engl J Med 326:22-29, 1992
17. Yoneda H, Ikegami H, Yamamoto Y, Yamato E, Cha T, Kawaguchi Y, Tahara Y, Ogihara T: Analysis of early-phase insulin responses in nonobese subjects with mild glucose intolerance. Diabetes Care 15:1517-1521, 1992
18. Martin BC, Warram JH, Krolewski AS, Bergman RN, Soeldner S, Kahn CR: Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet 340:925-929, 1992
19. O'Rahilly SP, Nugent Z, Rudenski AS, Hosker JP, Bumett MA, Darling R Turner RC: Beta-cell dysfunction, rather than insulin insensitivity, is the primary defect in familial type 2 diabetes. Lancet 2:360-364, 1986
20. Wang PH, Korc M: Searching for the Holy Grail: the cause of diabetes. Lancet 346 (Suppl.):4, 1995
21. Nishi S, Seino Y, Ishida H, Seno M, Taminato T, Sakurai H, Imura H: Vagal regulation of insulin, glucagon, and somatostatin secretion in vitro in the rat. J Clin Invest 79:1191-1196, 1986
22. Kurose T, Seino Y, Nishi S, Tsuji K, Taminato T, Tsuda K, Imura H: Mechanism of sympathetic neural regulation of insulin, somatostatin, and glucagon secretion. Am J Physiol 258:E220-E227, 1990
23. Leahy JL, Cooper HE, Weir GC: Impaired insulin secretion associated with near normoglycemia: study in normal rats with 96-h in vivo glucose infusions, Diabetes 36:459-464, 1987
24. Folkow B, Di Bona GF, Hjemdahl P, Toren PH, Wallin BG: Measurements of plasma norepinephrine concentrations in human primary hypertension: a word of caution on their applicability for assessing neurogenic contributions, Hypertension 5:399-403, 1983
25. Peles E, Goldstein DS, Akselrod S, Nitzan H, Azaria M, Almog S, Dolphin D, Halkin H, Modan M: Interrelationships among measures of autonomic activity and cardiovascular risk factors during orthostasis and the oral glucose tolerance test. Clin Auton Res 5:271-278, 1995